The pharmacokinetics of PEGylated liposomal doxorubicin are not significantly affected by sex in rats or humans, but may be affected by immune dysfunction

Christopher N. Subasic, Esther Kuilamu, Gary Cowin, Rodney F. Minchin, Lisa M. Kaminskas